{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T17:08:09Z","timestamp":1654708089017},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/mjt.0b013e31819df9cd","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T08:15:25Z","timestamp":1269418525000},"page":"e100-e104","source":"Crossref","is-referenced-by-count":1,"title":["Statins and Cancer: A Potential Link?"],"prefix":"10.1097","volume":"17","author":[{"given":"Joseph S","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R4-12-20210202","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.","volume":"359","author":"Rossebo","year":"2008","journal-title":"N Engl J Med"},{"key":"R5-12-20210202","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia.","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"R6-12-20210202","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1194\/jlr.M600439-JLR200","article-title":"The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin.","volume":"48","author":"Telford","year":"2007","journal-title":"Journal of Lipid Research"},{"key":"R7-12-20210202","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: mechanism of action and effects.","volume":"5","author":"Stancu","year":"2001","journal-title":"J Cell Mol Med"},{"key":"R8-12-20210202","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1056\/NEJMsa0801461","article-title":"Use of ezetimibe in the United States and Canada.","volume":"358","author":"Jackevicius","year":"2008","journal-title":"N Engl J Med"},{"key":"R9-12-20210202","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.0500269102","article-title":"The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).","volume":"102","author":"Arcia-Calvo","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-12-20210202","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5551\/jat.14.99","article-title":"Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.","volume":"14","author":"Davis","year":"2007","journal-title":"J Atheroscler Thromb"},{"key":"R11-12-20210202","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cmet.2008.04.001","article-title":"The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.","volume":"7","author":"Ge","year":"2008","journal-title":"Cell Metabolism"},{"key":"R12-12-20210202","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/14779072.6.6.781","article-title":"Is it over for ezetimibe?","volume":"6","author":"Robinson","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R13-12-20210202","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI30060","article-title":"Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.","volume":"117","author":"Temel","year":"2007","journal-title":"J Clin Invest"},{"key":"R14-12-20210202","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.atherosclerosis.2007.10.012","article-title":"Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI\/apoE double knockout mice.","volume":"198","author":"Braun","year":"2008","journal-title":"Atherosclerosis"},{"key":"R15-12-20210202","first-page":"1113","article-title":"Ezetimibe in search of receptor(s)-still a never-ending challenge in cholesterol absorption and transport.","volume":"1771","author":"Spener","year":"2007","journal-title":"Biochem Biophys Acta"},{"key":"R16-12-20210202","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1194\/jlr.M400475-JLR200","article-title":"Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption.","volume":"46","author":"Repa","year":"2005","journal-title":"Journal of Lipid Research"},{"key":"R17-12-20210202","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3949\/ccjm.75.7.497","article-title":"Given the ENHANCE trial results, ezetimibe is still unproven.","volume":"75","author":"Taylor","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"R18-12-20210202","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.amjcard.2006.10.064","article-title":"Design and baseline characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study.","volume":"99","author":"Rossebo","year":"2007","journal-title":"Am J Cardiol"},{"key":"R20-12-20210202","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.1987.03390070063024","article-title":"Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial.","volume":"257","author":"Sherwin","year":"1987","journal-title":"JAMA"},{"key":"R21-12-20210202","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.1996.03530250059028","article-title":"Carcinogenicity of lipid-lowering drugs.","volume":"275","author":"Newman","year":"1996","journal-title":"JAMA"},{"key":"R22-12-20210202","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacc.2007.02.073","article-title":"Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis and cancer.","volume":"50","author":"Alsheikh-Ali","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R23-12-20210202","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial.","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"R24-12-20210202","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/aje\/kwn141","article-title":"Statin use and risk of prostate cancer: results from a population-based epidemiologic study.","volume":"168","author":"Agalliu","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R25-12-20210202","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ijc.23597","article-title":"HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors.","volume":"123","author":"Borgquist","year":"2008","journal-title":"Int J Cancer"},{"key":"R26-12-20210202","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0895-4356(88)90056-X","article-title":"Serum cholesterol and risk of cancer in a cohort of 39,000 men and women.","volume":"41","author":"Knekt","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"R27-12-20210202","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.294.19.2492","article-title":"The IDEAL cholesterol.","volume":"294","author":"Cannon","year":"2005","journal-title":"JAMA"},{"key":"R28-12-20210202","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1200\/JCO.2006.06.3560","article-title":"Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.","volume":"24","author":"Bonovas","year":"2006","journal-title":"J Clin Oncol"},{"key":"R29-12-20210202","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.295.1.74","article-title":"Statins and cancer risk: a meta-analysis.","volume":"295","author":"Dale","year":"2006","journal-title":"JAMA"},{"key":"R30-12-20210202","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/1055-9965.EPI-06-0737","article-title":"Statin use and breast cancer risk in a large population-based setting.","volume":"16","author":"Boudreau","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R32-12-20210202","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMsa0806603","article-title":"Analyses of cancer data from three ezetimibe trials.","volume":"359","author":"Peto","year":"2008","journal-title":"N Engl J Med"},{"key":"R33-12-20210202","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djj188","article-title":"Statin use and breast cancer: prospective results from the Womens Health Initiative.","volume":"98","author":"Cauley","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R34-12-20210202","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/jnci\/djj499","article-title":"Statin drugs and risk of advanced prostate cancer.","volume":"98","author":"Platz","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R35-12-20210202","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1523-1755.63.s84.4.x","article-title":"Study of Heart and Renal Protection (SHARP).","volume":"84","author":"Baigent","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"R36-12-20210202","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1586\/14779072.6.3.385","article-title":"Aortic sclerosis, aortic stenosis and lipid-lowering therapy.","volume":"6","author":"Rosenhek","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e31819df9cd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:34:45Z","timestamp":1620963285000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201007000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e31819df9cd","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}